Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Next: Coffee mornings¬†galore!

    Coffee mornings are held at the Macmillan Centre, Southmead Hospital, on the first Thursday of each month (10am-12.30), to help new patients. Members needed to help man the event Рcontact chairman Malcolm. The next BAWA meeting will be an informal one on September 26. There is a push to get more SW men involved in prostate cancer clinical trials. A list of open trials in our area is here. We are grateful to the Unite union, who have given us £500.

  • Southmead seeks help

    Southmead  Hospital has asked Prospect for help to promote its appeal for funds to buy extra robotic surgery equipment. If you have had robotic surgery and would like to help by telling your story contact chairman Malcolm Gamlin. But beware of scammers making cold calls asking for funds in aid of the appeal. More information here.

  • Abiraterone ‘success’

    One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. Abiraterone, when used for treating prostate cancer that has spread, was found to save lives when offered earlier, a study found (June ’17). See

  • Financial help offered

    Members and family are invited to free sessions on financial wellbeing in Bristol. They are being run by St Bernard Support (SBS), a charity that provides support and services to people affected by life-affecting illnesses. The next sessions are on August 29 and November 28 at The Wellington, Gloucester Road, Horfield, Bristol BS7 8UR. SBS can also provide one-to-one arrangements if a person requires a discussion in depth or in privacy to discuss their needs.

  • New blood test and PSA guidance

    A blood test that could one day be used to identify cancers that are resistant to abiraterone and enzalutamide has been developed by researchers funded by Prostate Cancer UK with support from the November Foundation (May ’17). See. And the government reissued guidance on the benefits and risks of PSA tests. The aim is to help primary care teams give men with no symptoms information about the potential benefits, limitations and implications of the test (Apr 2017). See.

     

  • Monitoring ‘wins’

    Active monitoring is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind. The ProtecT trial was led by researchers at the Universities of Oxford and Bristol in nine UK centres. See

  • Alternative to biopsies?

    US researchers have developed a new way to capture cancer-derived particles called exosomes from prostate cancer, a finding that could offer an alternative to biopsies.  See

  • Two new breakthroughs

    A new approach by the University of East Anglia to mathematical modelling of prostate cancer has made it possible to spot potentially life-threatening tumours, allowing doctors to selectively offer aggressive treatment to those in need. See. And a new technique using tiny plastic beads to block the blood supply and shrink the enlarged prostate has had a successful trial in Portugal and is being followed up in Britain. See

  • Advanced MRI scans – a big leap

    The biggest leap in diagnosing prostate cancer “in decades” has been made using new advanced MRI scanners. See. Also this. But only a third of men can benefit, says Prostate Cancer UK. See. And a US study found a link between brisk walking and lowered risk of prostate cancer progression. See.¬†

  • Radium-223 decision

    The National Institute for Health and Care Excellence (NICE) announced in January its final decision to make radium-223 available on the NHS for men with hormone-resistant prostate cancer that has spread to the bones¬†‚Äď but only if they’ve been treated with chemotherapy. See.¬†

  • Docetaxel breakthrough

    The NHS confirmed in January that the chemotherapy drug docetaxel will be made available to prostate cancer patients as soon as they are diagnosed instead of having to wait until other treatments stop working. See. More news on the newsletter page.

Running

A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us:

0800 035 5302

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Phone volunteers needed

Prostate Cancer UK needs more telephone support volunteers. This  service is provided by trained volunteers who support men affected by prostate cancer and their loved ones, by sharing their experiences of treatments. Apply at.

Having the conversation…

‚ÄúManversation‚ÄĚ is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form.¬†Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked

10 prostate cancer myths debunked. See

New information for at-risk black men

One in four black men will get prostate cancer Рdouble the overall risk faced by all UK men. Are you are risk? See

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March, recognises teams working together to deliver improved patient care and public health. See a video about their work here. The classes are designed for people who have been affected by cancer and whose quality of life can be maintained or improved by taking part in regular, supervised exercise with cancer specialist instructors. Energise is a partnership between Macmillan, North Bristol NHS Trust, Sports Leisure Management Ltd and Bristol City Council. In a Bristol Post article on the Easton scheme participants tell how it helped them improve mood, vitality and well-being, and to overcome cancer-related fatigue. For more information on Energise see our Helpful links page.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties to replace Sandy Tyndale-Biscoe of Cornwall. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. See. In addition, he or she will participate in occasional meetings or teleconferences. If any Prospect member would like to volunteer for this rewarding role, they can email roger.wotton@tackleprostate.org All expenses are reimbursed.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See. And we have more research news here.

Swedish test shows promise

Swedish researchers found a test which¬†is a potentially a game-changing step forward for prostate cancer risk assessment. It involved genetic and protein biomarkers (the S3M) and was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence the S3M risk assessment model can dramatically cut the number of unnecessary biopsies, without compromising patients’ safety. But Prostate Cancer UK says it‚Äôs going to be important to validate this study in a more diverse population before it¬†can accept that it will work elsewhere. It¬†is funding more research to develop a new UK risk assessment tool. These plans are still going full steam ahead, and PCa UK¬†expects to have more to say about this¬†in 2017.¬†See.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options and consequences, thanks to a checklist developed by Aberdeen University researchers (Jun ’17). See.

    And why it’s¬†difficult to choose among treatment options (Jul ’17). See.

  • Buddies offer home support

    This Macmillan service offers support for adult cancer patients in their homes in Bristol, North Somerset and South Gloucestershire for up to 12 weeks.

    Ring 07543 248714 or email bristolbuddies@macmillan.org.uk